Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
GHK-Cu (Scalp) vs SNAP-8
An educational, source-based comparison of GHK-Cu (Scalp) and SNAP-8 — how each peptide works, what it's researched for, and what to know before going deeper.
Topical GHK-Cu applied to the scalp has been studied for its ability to enlarge hair follicles, prolong the anagen growth phase, and improve perifollicular vascularization through copper-dependent gene modulation.
- Follicle size and anagen phase
- Perifollicular angiogenesis
- Post-procedure scalp recovery (microneedling, transplant)
- • Topical use has a long cosmetic safety record.
- • Not a replacement for evidence-based therapies like minoxidil or finasteride.
An elongation of the better-known Argireline (Acetyl Hexapeptide-3). Research suggests it modulates SNARE complex formation, reducing the muscle contractions that drive expression lines in topical cosmetic studies.
- Expression-line depth (forehead, crow's feet)
- Skin smoothness endpoints
- • Topical-only application is well tolerated.
- • Effects are modest compared to neurotoxin injectables.
Trial-evidence rating
Educational grade reflecting how many peer-reviewed studies and FDA actions we cite for each peptide. Not a clinical recommendation.
Early-stage research; conclusions are tentative.
Early-stage research; conclusions are tentative.
Study-by-study comparison
| Peptide | Study | Source | Year | Summary |
|---|---|---|---|---|
| GHK-Cu (Scalp) | Copper peptides and hair growth | Journal of the American Academy of Dermatology | 2007 | Reported follicular stimulation and improved hair density in early trials. |
| SNAP-8 | Acetyl octapeptide-3 and expression wrinkles | International Journal of Cosmetic Science | 2013 | Reported reduction in wrinkle depth versus placebo in topical trial. |
Side-effect & safety grid
- Topical use has a long cosmetic safety record.
- Not a replacement for evidence-based therapies like minoxidil or finasteride.
- Topical-only application is well tolerated.
- Effects are modest compared to neurotoxin injectables.
Educational summary of considerations reported in research literature — not a complete list of adverse events. Discuss with a licensed clinician before any use.
GHK-Cu (Scalp) vs SNAP-8 — Key differences
- Class: GHK-Cu (Scalp) is classified as Hair · Follicle Health, while SNAP-8 is Skin · Cosmetic.
- Primary research focus: GHK-Cu (Scalp) — follicle size and anagen phase; SNAP-8 — expression-line depth (forehead, crow's feet).
- Tag: Hair vs Skin.